The US Senate's permanent subcommittee on investigations has decided to look into Mylan Pharmaceuticals' pricing of the EpiPen, according to a press release issued on Wednesday. The release described the probe as a 'preliminary inquiry.'
(photo credit: The Jerusalem Post)